ELITE PHARMACEUTICALS

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

February 15, 2006

Accession Number

0000947871-06-000324

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →